These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30381621)

  • 1. L-Carnitine for the Treatment of Overt Hepatic Encephalopathy in Patients with Advanced Liver Cirrhosis.
    Tajiri K; Futsukaichi Y; Kobayashi S; Yasumura S; Takahara T; Minemura M; Sugiyama T
    J Nutr Sci Vitaminol (Tokyo); 2018; 64(5):321-328. PubMed ID: 30381621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma.
    Iwasa M; Sugimoto R; Ishihara T; Sekoguchi-Fujikawa N; Yoshikawa K; Mifuji-Moroka R; Tanaka H; Kobayashi Y; Hasegawa H; Takei Y
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(6):433-40. PubMed ID: 26875483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.
    Malaguarnera M; Risino C; Cammalleri L; Malaguarnera L; Astuto M; Vecchio I; Rampello L
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):762-70. PubMed ID: 19357525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-carnitine reduces hospital admissions in patients with hepatic encephalopathy.
    Tani J; Morishita A; Sakamoto T; Takuma K; Nakahara M; Fujita K; Oura K; Tadokoro T; Mimura S; Nomura T; Yoneyama H; Kobara H; Himoto T; Masaki T
    Eur J Gastroenterol Hepatol; 2021 Feb; 32(2):288-293. PubMed ID: 32925502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival benefit of l-carnitine supplementation in patients with cirrhosis.
    Miwa T; Hanai T; Nishimura K; Sakai Y; Imai K; Suetsugu A; Takai K; Shiraki M; Katsumura N; Shimizu M
    JPEN J Parenter Enteral Nutr; 2022 Aug; 46(6):1326-1334. PubMed ID: 35511698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of L-carnitine in patients with hepatic encephalopathy.
    Malaguarnera M; Pistone G; Elvira R; Leotta C; Scarpello L; Liborio R
    World J Gastroenterol; 2005 Dec; 11(45):7197-202. PubMed ID: 16437672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between interleukin-6 and ammonia in patients with overt hepatic encephalopathy due to cirrhosis.
    Luo M; Li L; Yang EN; Dai CY; Liang SR; Cao WK
    Clin Res Hepatol Gastroenterol; 2013 Sep; 37(4):384-90. PubMed ID: 23084463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic encephalopathy - recent advances in treatment and diagnosis.
    Nardelli S; Gioia S; Faccioli J; Riggio O; Ridola L
    Expert Rev Gastroenterol Hepatol; 2023 Mar; 17(3):225-235. PubMed ID: 36843291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-Carnitine in the treatment of mild or moderate hepatic encephalopathy.
    Malaguarnera M; Pistone G; Astuto M; Dell'Arte S; Finocchiaro G; Lo Giudice E; Pennisi G
    Dig Dis; 2003; 21(3):271-5. PubMed ID: 14571103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
    Kawaguchi T; Taniguchi E; Sata M
    Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of minimal and overt hepatic encephalopathy with branched-chain amino acids: a review of the evidence.
    Swansson WD; Anderson BM; Yeoh SW; Lewis DJ
    Eur J Gastroenterol Hepatol; 2023 Aug; 35(8):812-821. PubMed ID: 37395232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat.
    Therrien G; Rose C; Butterworth J; Butterworth RF
    Hepatology; 1997 Mar; 25(3):551-6. PubMed ID: 9049197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous versus oral 'L-ornithine-L-aspartate' in overt hepatic encephalopathy: a randomized comparative study.
    Jhajharia A; Singh S; Jana S; Ashdhir P; Nijhawan S
    Sci Rep; 2024 May; 14(1):11862. PubMed ID: 38789596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].
    Chen MF; Li RC; Chen CH; Gao XC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):718-9, 722. PubMed ID: 15958319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Ammonia Levels Do Not Correlate With Overt Hepatic Encephalopathy Severity in Hospitalized Patients With Cirrhosis.
    Bajaj JS; Pyrsopoulos NT; Rahimi RS; Heimanson Z; Allen C; Rockey DC
    Clin Gastroenterol Hepatol; 2024 Sep; 22(9):1950-1952.e1. PubMed ID: 38423347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral BCAA supplementation in cirrhosis with chronic encephalopathy: effects on prolactin and estradiol levels.
    Bianchi GP; Marchesini G; Zoli M; Abbiati R; Ferrario E; Fabbri A; Pisi E
    Hepatogastroenterology; 1992 Oct; 39(5):443-6. PubMed ID: 1459529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study.
    Weiss N; Tripon S; Lodey M; Guiller E; Junot H; Monneret D; Mayaux J; Brisson H; Mallet M; Rudler M; Imbert-Bismut F; Thabut D;
    Fundam Clin Pharmacol; 2018 Apr; 32(2):209-215. PubMed ID: 29239015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.